(Vax-Before-Travel News)In the Republic of Indonesia, the extreme rainfall and floods that struck Sumatra in late November 2025 unleashed devastating humanitarian impacts. According to the Meteorology, Climatology, and Geophysics Agency, areas in Sumatra, …

… highlighted the FDA’s approval of a treatment for … underlying medical conditions, developed severe illness and was … Institute of Allergy and Infectious Diseases and the NIMHD … 041, respectively). Overall, infectious disease trials were the most affected …

… 39;s only one quick, FDA‑approved test for detecting the … delay keeps them from starting treatment quickly, especially those who … treatment in the same visit. "We were able to develop … in The Journal of Infectious Diseases. Source: Northwestern University

… School of Science from a pharmaceutical career at Eli Lilly and … to find drugs for developing world diseases, neglected diseases and infectious diseases.” D3’s … goal is to accelerate drug discovery for developing and …

… Seika Pharma collaborates with MBC BioLabs for global innovation in drug discovery … strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases …

… the Food and Drug Administration is not … for Infectious Diseases. Prasad's framework, however, treats uncertainty … business effects. Vaccine development is costly, and … Kathryn Edwards, a pediatric infectious disease specialist at Vanderbilt University …

… on developing and commercializing products to treat rare … drugs are also used, including anti-TNF medications. The only approved drug … Institute of Allergy and Infectious Diseases (NIAID), the Defense … Phase 3 clinical trial for the treatment of cutaneous T- …

… Lilly said its oral obesity pill helped maintain weight loss in … has filed for FDA approval for the drug. (CNBC) The Infectious Diseases Society of … . National Institute of Allergy and Infectious Diseases, and will assume her new …

… of the Centre for Infectious Disease Research at the Indian … -the-counter drug widely used to treat nausea and … anti-TB drugs, with no signs of harmful drug-drug interactions. … addition to improving treatment efficacy, a drug combination including meclizine …

… development in its priority therapeutic areas: infectious diseases … innovative drug … infectious diseases, therapeutics for central nervous system diseases and generic drugs … PHARMACEUTICAL HEALTH INFECTIOUS DISEASES HEALTH TECHNOLOGY SOURCE: Meiji Seika Pharma …